AyushNet
Ayurvedic perspective on polycystic ovarian syndrome and the role of Satapushpa and Tilatailam
Article

Ayurvedic perspective on polycystic ovarian syndrome and the role of Satapushpa and Tilatailam

Introduction

Modern lifestyle changes, including sedentary habits, altered dietary patterns, and increasing stress, have made women more vulnerable to various health disorders. Polycystic Ovarian Syndrome (PCOS) is one such condition that affects reproductive health and can impair a woman’s ability to conceive. Globally, the prevalence of PCOS is estimated to range between 3% and 10%, making it a significant health concern among women of reproductive age. 1

Understanding PCOS

PCOS is commonly described as a disorder characterized by hormonal imbalance and is believed to have a genetic basis. Despite its high prevalence, diagnosis and differential diagnosis can be challenging due to the diverse clinical manifestations associated with the condition.

Key features of PCOS include:

  • Hormonal dysregulation affecting normal ovarian function.
  • Reproductive disturbances that may impact fertility.
  • Variable clinical presentation requiring individualized evaluation and management.
  • Long-term health concerns associated with conventional therapeutic approaches.

Management is often guided by the primary concerns of the patient and healthcare provider, allowing treatment strategies to be tailored according to clinical priorities. 2

Ayurvedic interpretation of PCOS

Ayurveda evaluates disease based on the involvement of Doshas and Dushyas rather than relying solely on disease nomenclature. This approach allows emerging clinical disorders to be understood through their symptomatology and underlying pathophysiological mechanisms.

Within the Ayurvedic framework:

  • The clinical presentation of PCOS resembles Pushpaghni Jathaharini, as described by Acharya Kasyapa in Revathi Kalpa Adhyaya.
  • The pathological basis of the condition is closely associated with Nashtarthava, a disease entity described by Acharya Susrutha.
  • Disease assessment focuses on identifying the disturbed physiological processes responsible for symptom manifestation rather than assigning a specific modern diagnostic label. 3

Role of Satapushpa and Tilatailam

The Ayurvedic management of PCOS emphasizes correcting the underlying imbalance responsible for reproductive dysfunction.

Important observations regarding the use of Satapushpa powder and Tilatailam include:

  • Administration over a period of three months helps regularize menstrual intervals.
  • Improvement in menstrual cyclicity reflects restoration of reproductive function.
  • Reduction in ovarian volume has also been observed alongside menstrual regulation.

These effects highlight the potential relevance of Ayurvedic therapeutic approaches in addressing the clinical manifestations associated with PCOS.

Conclusion

PCOS is a common reproductive disorder influenced by hormonal imbalance, genetic predisposition, and lifestyle-related factors. Ayurveda interprets the condition through concepts such as Pushpaghni Jathaharini and Nashtarthava, focusing on the underlying Dosha-Dushya involvement rather than disease nomenclature alone. The use of Satapushpa powder and Tilatailam demonstrates a therapeutic approach aimed at restoring menstrual regularity and improving ovarian health, reflecting the individualized and pathology-based principles of Ayurvedic management. 4

References:

1. Bellver J, Rodríguez-Tabernero L, Robles A, et al. Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet. 2018;35(1):25-39. doi:10.1007/s10815-017-1047-7. https://pmc.ncbi.nlm.nih.gov/articles/PMC5758469/

2. Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity. Int J Environ Res Public Health. 2018;15(11):2589. Published 2018 Nov 20. doi:10.3390/ijerph15112589. https://pmc.ncbi.nlm.nih.gov/articles/PMC6266413/

3. Bates GW, Legro RS. Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol. 2013;373(1-2):91-97. doi:10.1016/j.mce.2012.10.029. https://pmc.ncbi.nlm.nih.gov/articles/PMC4367484/

4. Jacob J, Vijayakumar N, Olickal JJ. Effect of satapushpa churnam with tila tailam in oligomenorrhea associated with polycystic ovarian syndrome. J Ayurveda Integr Med. 2021;12(4):695-699. doi:10.1016/j.jaim.2021.06.015. https://pmc.ncbi.nlm.nih.gov/articles/PMC8642696/#sec5